Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION

Orpha-Devel Handels Und Vertriebs Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 21, 2024
Approval ID: 29df93f751f26433
Company: Orpha-Devel Handels Und Vertriebs Gmbh
Type: Standard

Approval Details

Approval Id: 29df93f751f26433
Drug Cima Aemps Name: RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION
Register Number: 89271
Holder Company Name: Orpha-Devel Handels Und Vertriebs Gmbh
Marketing Company Name: Aop Orphan Pharmaceuticals Iberia, S.L.U
Authorization Date: 2024-02-21
Dosage Form: POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 300 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Orpha-Devel Handels Und Vertriebs Gmbh

Active Ingredients

LANDIOLOL HIDROCLORURO

300 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 21, 2024

Approval ID

29df93f751f26433

Type

Standard

Back to CIMA-AEMPS Approvals